| Dr Catherine Ann Counard, MD | |
|
5127 Oakton St, Skokie, IL 60077-3633 | |
| (847) 933-8252 | |
| (847) 673-8606 |
| Full Name | Dr Catherine Ann Counard |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 5127 Oakton St, Skokie, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992827232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 036-097634 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Catherine Ann Counard, MD 5127 Oakton St, Skokie, IL 60077-3633 Ph: (847) 933-8252 | Dr Catherine Ann Counard, MD 5127 Oakton St, Skokie, IL 60077-3633 Ph: (847) 933-8252 |
News Archive
A team of researchers from the Institute for Research in Immunology and Cancer of the Universit- de Montr-al have defined for the first time the mechanism behind three cancer-causing genes in acute lymphoblastic leukemia. Published in the journal Genes and Development, the findings offer insight on the complex interaction between the genes and their contributions to leukemia, thereby providing the foundation for the design of targeted therapies.
The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.
Investigators at the Dana-Farber/Harvard Cancer Center in Boston became intrigued with the thick, slimy stuff when they learned that breast, lung, colon, and other tumor cells make more than 50 times more of a certain type of it than normal cells.
A recent study by researchers from the Netherlands highlights that the introduction of vaccination programs against coronavirus disease 2019 (COVID-19) to adolescents and children may reduce infection rates and severe disease outcomes – both in these age groups and in the population as a whole. The paper is currently available on medRxiv* preprint server while it undergoes peer review.
› Verified 9 days ago
Jamie Lynn Kondelis, Preventive Medicine Medicare: Medicare Enrolled Practice Location: 5540 Touhy Ave, Skokie, IL 60077 Phone: 847-647-0355 |